Dhankhar Anushikha, Khobragade Pranali, Banerjee Joyita, Chopra Geeta, Jacob Steffi, Dey A B, Lee Jinkook, Crimmins Eileen, Thyagarajan Bharat, Dey Sharmistha, Hu Peifeng
Center for Economic and Social Research, University of Southern California, Los Angeles, California, United States of America.
Metropolis Healthcare Ltd., Delhi, India.
PLoS One. 2025 Jul 31;20(7):e0326917. doi: 10.1371/journal.pone.0326917. eCollection 2025.
The prevalence of dementia is on the rise, with 60% of dementia cases existing in low- and middle-income countries. In India, the prevalence was reported to be 7.4%. Since the pathophysiology of dementia is multifactorial, the Harmonized Longitudinal Aging Study in India for the Diagnostic Assessment of Dementia (LASI-DAD) collected data to capture multiple domains, including venous blood specimens (VBS). VBS collection and assays help ascertain the overall health status of an individual, understand disease pathogenesis, and diagnose diseases. In community settings, blood assays also help identify disease trends. However, community VBS collections can often be challenging. Sample quality can be impaired due to individual, environmental, geographical, and pre-analytical processing factors. Therefore, standardization of the process is imperative to ensure biomarker data of high accuracy. LASI-DAD developed a systematic sample collection, shipment, processing, and storage protocol. Multiple checkpoints were in place to monitor sample quality in real time. A phlebotomist was trained from each participating state for specimen collection. All samples were centrally tested for analytes. The overall response rate for blood collection was 71.5%. We collected 17 mL of VBS from 3,252 respondents, who consented to participate. Blood samples were tested for routine analytes, and those specific to Alzheimer's Disease (AD) and AD-related dementias (ADRD). Data was reviewed fortnightly. The median cold chain temperature was 6.2°C and hemolysis was seen in 6.7% of the samples. LASI-DAD standardized and implemented VBS collection while overcoming the challenges faced due to India's diverse socio-demographic, geographical, and environmental conditions. This methodology can serve as a robust tool for VBS handling and ensuring high sample quality for future community-based studies.
痴呆症的患病率正在上升,60%的痴呆症病例存在于低收入和中等收入国家。在印度,据报道患病率为7.4%。由于痴呆症的病理生理学是多因素的,印度痴呆症诊断评估统一纵向老龄化研究(LASI-DAD)收集数据以涵盖多个领域,包括静脉血样本(VBS)。VBS的采集和检测有助于确定个体的整体健康状况、了解疾病发病机制并诊断疾病。在社区环境中,血液检测还有助于识别疾病趋势。然而,社区VBS的采集往往具有挑战性。由于个体、环境、地理和分析前处理因素,样本质量可能会受到影响。因此,必须对该过程进行标准化,以确保获得高精度的生物标志物数据。LASI-DAD制定了系统的样本采集、运输、处理和存储方案。设置了多个检查点以实时监测样本质量。从每个参与州培训一名采血员进行样本采集。所有样本都集中检测分析物。血液采集的总体响应率为71.5%。我们从3252名同意参与的受访者中采集了17毫升VBS。对血样进行常规分析物以及阿尔茨海默病(AD)和AD相关痴呆症(ADRD)特异性分析物的检测。每两周对数据进行审查。冷链温度中位数为6.2°C,6.7%的样本出现溶血。LASI-DAD在克服因印度多样的社会人口、地理和环境条件所面临的挑战的同时,对VBS采集进行了标准化并予以实施。这种方法可以作为VBS处理的有力工具,并为未来基于社区的研究确保高样本质量。